Received Mar 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 3 | UNK | — |
missed the booster; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a 5-year-old male patient who received Men B NVS (Bexsero) for prophylaxis. Previously administered products included Bexsero (received 2 doses on an unknown date). On an unknown date, the patient did not receive the 3rd dose of Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced incomplete course of vaccination (Verbatim: missed the booster). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 12-MAR-2025 This case was reported by a patient via (Bexsero GSK Cht bot) interactive digital media. The reporter reported that the patient had bexero vaccine when he was 19 months and 21months old, so two doses in total. The reporter was ask did he need 3rd booster dose. Till the time of reporting, the patient did not receive 3rd dose of Bexsero, which led to incomplete course of vaccination.